Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network
Rhea-AI Summary
Tharimmune (NASDAQ: THAR) commented on the DTCC and Digital Asset partnership to tokenize U.S. Treasury securities on the Canton Network announced December 18, 2025. The company highlighted that DTCC custody covers ~$30 trillion in U.S. Treasuries and noted Canton Network's $9 trillion monthly transaction volume and >700,000 daily transactions as validation of institutional blockchain adoption.
Tharimmune said it established a digital asset treasury strategy in November 2025 with a $545 million private placement, has acquired Canton Coin, and is pursuing roles as a Super Validator and application investor to support Canton Network expansion.
Positive
- $545 million private placement launched in November 2025
- $9 trillion monthly transaction volume on Canton Network
- DTCC custody represents ~$30 trillion in U.S. Treasury assets
- Pursuing Super Validator and application investor roles on Canton Network
Negative
- None.
News Market Reaction – THAR
In the Dec 18 session, THAR declined 5.93%, reflecting a notable negative market reaction. Argus tracked a peak move of +2.4% during that session. Argus tracked a trough of -7.6% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 12 | CFO appointment | Neutral | -5.5% | New CFO to oversee capital planning and Canton Coin treasury expansion. |
| Nov 13 | FDA feedback TH104 | Positive | -6.5% | FDA concurred with TH104 PK modeling plan toward potential 505(b)(2) NDA. |
| Nov 06 | Private placement close | Positive | +4.0% | Closed $545M raise at $3.075 to fund Canton Coin strategy. |
| Nov 03 | Private placement announce | Positive | +8.5% | Announced ~$540M private placement to launch Canton Coin treasury. |
| Aug 20 | TH104 PK results | Positive | +206.8% | Positive TH104 simulations with ~30-min onset and ~24-hour protection. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
THAR has seen strong positive reactions to financing and strategic Canton Coin announcements, but recent biotech and corporate updates have sometimes been met with negative moves, indicating inconsistent reactions to fundamentally positive news.
Over the last six months, Tharimmune has blended biotech progress with a major digital-asset strategy shift. Positive TH104 pharmacokinetic data on Aug 20, 2025 coincided with a +206.84% move. In early November, a announced and then closed private placement of about $540–545 million to fund its Canton Coin treasury strategy saw shares rise 8.47% and 4.01%. More recently, positive FDA feedback on TH104 on Nov 13 and a CFO appointment tied to the Canton strategy on Dec 12 were followed by -6.52% and -5.53% moves, respectively. Today’s DTCC/Canton commentary builds on this digital-asset focus.
Key Terms
tokenize financial
U.S. Treasury securities financial
repo transactions financial
programmable privacy technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Milestone Underscores Accelerating Institutional Adoption of Blockchain Technology and Aligns with Tharimmune's Canton Coin Treasury Strategy
Mark Wendland, CEO of Tharimmune, commented:
"DTCC's announcement represents another meaningful step in the structural shift toward onchain financial rails. With more than
Institutional adoption of blockchain technology depends on a critical capability that the Canton Network uniquely delivers: programmable privacy. The configurable privacy on the Canton Network allows market participants to capitalize on instantaneous settlement without disclosing the "who" behind the trade to any party other than authorized counterparties and regulators.
We see the value proposition of the Canton Network becoming increasingly tangible, having recently reached
Tharimmune established its digital asset treasury strategy in November 2025 with a
About Tharimmune
Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit www.tharimmune.com.
Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements" within the meaning of
Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com
Investors:
ir@tharimmune.com
Twitter/X: @TharimmuneInc
LinkedIn: https://www.linkedin.com/company/tharimmune-inc
Website: https://tharimmune.com
View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-statement-on-dtccs-initiative-to-tokenize-us-treasury-securities-on-the-canton-network-302645591.html
SOURCE Tharimmune, Inc.